Schütten H J, Henriksen J H, Warberg J
Clin Physiol. 1987 Apr;7(2):125-32. doi: 10.1111/j.1475-097x.1987.tb00154.x.
Arterial plasma immunoreactivity of endogenous human alpha-atrial natriuretic peptide (ANP) underwent mean 54%, 28% and 40% extraction during one passage through the circulation in the kidney (n = 12), liver-intestine (n = 14) and lower limb (n = 8), respectively, in supine fasting subjects with no detectable disease or subjects with cardiovascular or hepatic disorders of minor degree undergoing a haemodynamic investigation. No extraction was identified across the lungs as evaluated by the same concentration of ANP in pulmonary and femoral arteries (n = 7). The concentration of ANP in a superficial arm vein relative to the femoral artery varied considerably and extractions from 0% up to 58% were identified (mean 18%). The results suggest a high degree of, but only to some extent selective, extraction of ANP, which may account for its proposed short plasma half-life. Due to the different concentrations of ANP in various vascular beds, sampling site should be thoroughly specified.
在无明显疾病的仰卧禁食受试者或患有轻度心血管或肝脏疾病且正在接受血流动力学检查的受试者中,内源性人α-心房利钠肽(ANP)的动脉血浆免疫反应性在肾脏(n = 12)、肝肠(n = 14)和下肢(n = 8)的一次循环过程中,平均提取率分别为54%、28%和40%。通过肺循环时未发现有提取现象,这是通过肺动脉和股动脉中相同浓度的ANP评估得出的(n = 7)。相对于股动脉,浅表臂静脉中ANP的浓度差异很大,提取率从0%到58%不等(平均18%)。结果表明,ANP有高度但仅在一定程度上有选择性的提取,这可能解释了其血浆半衰期较短的原因。由于不同血管床中ANP浓度不同,采样部位应明确指定。